Trade this ETF at your broker
Index | JP Morgan Diversified Factor US Equity |
Investment focus | Equity, United States, Multi-Factor Strategy |
Fund size | EUR 15 m |
Total expense ratio | 0.20% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Actively managed |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 20.93% |
Inception/ Listing Date | 9 July 2019 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | J.P. Morgan |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Brown Brothers Harriman Fund Administration Services (Ireland) Ltd |
Investment Advisor | J. P. Morgan Investment Management Inc. (Sub-Delegate)|JPMorgan Asset Management (UK) Limited |
Custodian Bank | Brown Brothers Harriman Trustee Services Ireland Limited |
Revision Company | PricewaterhouseCoopers (Ireland) |
Fiscal Year End | 31 December |
Swiss representative | JPMorgan Asset Management (Switzerland) LLC |
Swiss paying agent | J.P. Morgan (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | Unknown | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Prologis Inc | 0.53% |
Steel Dynamics | 0.51% |
Eli Lilly & Co | 0.46% |
United Therapeutics Corp | 0.46% |
Marathon Oil Corp | 0.46% |
AbbVie | 0.46% |
Bristol Myers Squibb | 0.45% |
Lockheed Martin | 0.45% |
Nucor | 0.44% |
Vertex Pharmaceuticals | 0.44% |
United States | 89.71% |
Ireland | 1.41% |
Other | 8.88% |
Health Care | 12.68% |
Consumer Staples | 12.21% |
Technology | 10.53% |
Basic Materials | 8.93% |
Other | 55.65% |
YTD | +3.65% |
1 month | +2.36% |
3 months | -4.71% |
6 months | +3.84% |
1 year | +3.88% |
3 years | +41.84% |
5 years | - |
Since inception (MAX) | - |
2023 | +39.26% |
2022 | -1.94% |
2021 | - |
2020 | - |
Volatility 1 year | 20.93% |
Volatility 3 years | 24.87% |
Volatility 5 years | - |
Return per risk 1 year | 0.19 |
Return per risk 3 years | 0.50 |
Return per risk 5 years | - |
Maximum drawdown 1 year | - |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | - |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | JUMF | - - | - - | - |
Stuttgart Stock Exchange | EUR | JUMF | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | JPUSAN MM | JPUSAN.MX | |
Borsa Italiana | EUR | JPUS | JPUS IM JPUSEUIV | JPUS.MI JPUSEUiv.P | |
Frankfurt Stock Exchange | EUR | - | JPUSEUIV | JPUSEUiv.P | |
London Stock Exchange | GBX | JPSU | JPSUGBIV | JPUSGBiv.P | |
London Stock Exchange | USD | JPUS | JPUS LN JPUSUSIV | JPUS.L JPUSUSiv.P | |
London Stock Exchange | GBP | - | JPSU LN JPSUGBIV | JPSU.L JPUSGBiv.P | |
XETRA | EUR | JUMF | JUMF GY JPUSEUIV | JUMF.DE JPUSEUiv.P |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Franklin U.S. Equity UCITS ETF | 158 | 0.25% p.a. | Accumulating | Full replication |
UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 71 | 0.25% p.a. | Accumulating | Sampling |
iShares Edge MSCI USA Multifactor UCITS ETF | 69 | 0.35% p.a. | Accumulating | Sampling |
Goldman Sachs ActiveBeta US Large Cap Equity UCITS ETF CLASS USD (Acc.) | 50 | 0.14% p.a. | Accumulating | Full replication |
First Trust US Large Cap Core AlphaDEX UCITS ETF Acc | 40 | 0.65% p.a. | Accumulating | Full replication |